« Back
Home /
c-Met inhibitor 1

c-Met inhibitor 1

Item no.	CS-1557-5mg
Manufacturer	ChemScene
Amount	5mg
Category	Oncology By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Myeloma Melanoma Sarcoma Adenocarcinoma Mesothelioma Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Similar products	1357072-61-7
Available
CAS	1357072-61-7
Purity	>98%
Formula	C17H14N8S
MWt	362.41
Solubility	DMSO : 20 mg/mL (55.19 mM; Need ultrasonic)
Clinical Information	No Development Reported
Pathway	Protein Tyrosine Kinase/RTK
Target	c-Met/HGFR
Biological Activity	c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer. IC50 value: Target: c-Met More details please refer to Patent WO 2012015677 A1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CS-1557-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer